Trial · NCT03827798
Participant flow66
How many started, completed or left each group, period by period.
21 to 40 of 66
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Treatment Epoch | COMPLETED | Cohort E - VAY736 300 mg | 23 | |
| Treatment Epoch | COMPLETED | Cohort E - Placebo to VAY736 | 10 | |
| Treatment Epoch | NOT COMPLETED | Cohort A - CFZ533 600 mg | 4 | |
| Treatment Epoch | NOT COMPLETED | Cohort A - Placebo to CFZ533 | 4 | |
| Treatment Epoch | NOT COMPLETED | Cohort B - LYS006 20 mg | 7 | |
| Treatment Epoch | NOT COMPLETED | Cohort B - Placebo to LYS006 | 4 | |
| Treatment Epoch | NOT COMPLETED | Cohort C - MAS825 300 mg | 4 | |
| Treatment Epoch | NOT COMPLETED | Cohort C - Placebo to MAS825 | 1 | |
| Treatment Epoch | NOT COMPLETED | Cohort D - LOU064 25 mg | 4 | |
| Treatment Epoch | NOT COMPLETED | Cohort D - LOU064 100 mg | 7 | |
| Treatment Epoch | NOT COMPLETED | Cohort D - Placebo to LOU064 | 3 | |
| Treatment Epoch | NOT COMPLETED | Cohort E - VAY736 300 mg | 9 | |
| Treatment Epoch | NOT COMPLETED | Cohort E - Placebo to VAY736 | 1 | |
| Entered Post-treatment Follow-up | STARTED | Cohort A - CFZ533 600 mg | 26 | |
| Entered Post-treatment Follow-up | STARTED | Cohort A - Placebo to CFZ533 | 12 | |
| Entered Post-treatment Follow-up | STARTED | Cohort B - LYS006 20 mg | 21 | |
| Entered Post-treatment Follow-up | STARTED | Cohort B - Placebo to LYS006 | 9 | |
| Entered Post-treatment Follow-up | STARTED | Cohort C - MAS825 300 mg | 28 | |
| Entered Post-treatment Follow-up | STARTED | Cohort C - Placebo to MAS825 | 9 | |
| Entered Post-treatment Follow-up | STARTED | Cohort D - LOU064 25 mg | 30 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03827798/flow?page=2